← FDA Drug Approvals (Drugs@FDA)

ANDA216087

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LTD · Approved 2023-10-02

Drug application

FDA Application #

ANDA216087

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

MSN LABORATORIES PRIVATE LTD

First approval

2023-10-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown